Vortioxetine 10-20 mg

DRUG2 trials

Sponsors

H. Lundbeck A/S

Conditions

Major Depressive Disorder

Phase 3

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

CompletedNCT02272517

H. Lundbeck A/SMajor Depressive Disorder

Start: 2014-12-31End: 2016-03-31Updated: 2017-02-28

Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder

CompletedNCT02279953

H. Lundbeck A/SMajor Depressive Disorder

Start: 2014-10-31End: 2016-04-30Updated: 2017-05-24

Related Papers

Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings

Journal of Affective Disorders2018-11-059 citations